Skip to main content
. 2022 Jan 5;14(1):228. doi: 10.3390/nu14010228

Table 1.

Baseline characteristics of the subjects participating in the study.

All Volunteers
(n = 198)
Control Group
(n = 100)
Probiotic Group
(n = 98)
p between-Groups
Age (years) Mean ± SD 83.13 ± 9.13 83.97 ±8.99 82.28 ± 9.22 0.192
Median (IQR) 85 (77–90) 86 (77–90) 84 (77–90)
Nursing home 0.992
 Sta Olalla n (%) 39 (19.7%) 20 (20.0%) 19 (19.4%)
 San Marcos n (%) 91 (46%) 46 (46.0%) 45 (45.9%)
 San Simon n (%) 68 (34.3%) 34 (34.0%) 34 (34.7%)
Sex 0.356
 Men n (%) 73 (36.9%) 40 (40.0%) 33 (33.7%)
 Women n (%) 125 (63.1%) 60 (60.0%) 65 (66.3%)
Postural control 0.345
 Stand upright n (%) 138 (69.7%) 65 (65.0%) 73 (74.5%)
 Non-stand upright n (%) 21 (10.6%) 12 (12.0%) 9 (9.2%)
 Bedridden patient n (%) 39 (19.7%) 23 (23.0%) 16 (16.3%)
BMI (kg/m2) 1 Mean ± SD 26.63 ± 5.11 26.25 ± 4.92 26.96 ± 5.28 0.411
Obesity n (%) 42 (21.2%) 21 (21.0%) 21 (21.4%) 0.941
Low weight n (%) 34 (17.2%) 15 (15.0%) 19 (19.4%) 0.413
Smokers n (%) 18 (9.1%) 8 (8.0%) 10 (10.2%) 0.590
Former alcoholics n (%) 10 (5.1%) 4 (4.0%) 6 (6.1%) 0.495
Dyslipidemia n (%) 80 (40.4%) 38 (38.0%) 42 (42.9%) 0.486
Hypertension n (%) 125 (63.1%) 63 (63.0%) 62 (63.3%) 0.969
Diabetes Mellitus n (%) 47 (23.7%) 23 (23.0%) 24 (24.5%) 0.805
Cardiovascular Disease n (%) 77 (38.9%) 41 (41.0%) 36 (36.7%) 0.538
Cognitive Diseases 2 n (%) 91 (46.0%) 47 (47.0%) 44 (44.9%) 0.767
Chronic Lung Disease n (%) 27 (13.6%) 15 (15.0%) 12 (12.2%) 0.572
Renal disease n (%) 21 (10.6%) 12 (12.0%) 9 (9.2%) 0.520
Hepatic disease n (%) 7 (3.5%) 4 (4.0%) 3 (3.1%) 0.721
Previous cancer diagnosis n (%) 18 (9.1%) 3 (3.0%) 15 (15.3%) 0.003
Rheumatic diseases 3 n (%) 57 (28.8%) 27 (27.0%) 30 (30.4%) 0.562
Psychiatric diseases 4 n (%) 82 (41.4%) 36 (36.0%) 46 (46.9%) 0.118
Disease Index 5 Mean ± SD 3.20 ± 1.62 3.09 ± 1.66 3.32 ± 1.58 0.328
Median (IQR) 3 (2–4) 3 (2–4) 3 (2–4)
Number of habitual medications Median (IQR) 8 (5–11) 7.5 (5–10) 9 (6–11) 0.108

Values are mean ± SD and/or median (IQR) for continuous variables and n (%) for categorical variables. p indicates differences between the control group and the probiotic group 1. BMI were calculated in volunteers that stand upright 2. Cognitive Diseases included Alzheimer, Parkinson, and Dementia 3. Rheumatic diseases not under immunosuppressive therapies 4. Psychiatric diseases included bipolar disease, major depression, and schizophrenia 5. Disease Index included the sum of HTA, T2DM, CVD, Lung diseases, oncology disease in the past, rheumatology diseases, cognitive diseases, psychiatric diseases, renal diseases, hepatic diseases, and dyslipidemia.